Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CAPITAL AND CODEINE

ACETAMINOPHEN; CODEINE PHOSPHATE

Standard Dose
120MG/5ML;12MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CAPITAL AND CODEINE is listed in Drugs@FDA under application 086024 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength SUSPENSION;ORAL - 120MG/5ML;12MG/5ML Sponsor VALEANT PHARMS LLC Submission history Latest submission status date: 2018-01-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview CAPITAL AND CODEINE is listed in Drugs@FDA under application 086024 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength SUSPENSION;ORAL - 120MG/5ML;12MG/5ML Sponsor VALEANT PHARMS LLC Submission history Latest submission status date: 2018-01-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.